| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-72 |
DRI_Background |
denotes |
SOX11 promotes invasive growth and ductal carcinoma in situ progression. |
| T2 |
73-208 |
DRI_Outcome |
denotes |
Here, we show that SOX11, an embryonic mammary marker that is normally silent in postnatal breast cells, is expressed in many oestrogen |
| T3 |
209-238 |
Token_Label.OUTSIDE |
denotes |
receptor-negative preinvasive |
| T4 |
239-279 |
DRI_Outcome |
denotes |
ductal carcinoma in situ (DCIS) lesions. |
| T5 |
280-533 |
DRI_Background |
denotes |
Mature mammary epithelial cells engineered to express SOX11 showed alterations in progenitor cell populations, including an expanded basal-like population with increased aldehyde dehydrogenase (ALDH) activity, and increased mammosphere-forming capacity. |
| T6 |
534-649 |
DRI_Background |
denotes |
DCIS.com cells engineered to express SOX11 showed increased ALDH activity, which is a feature of cancer stem cells. |
| T7 |
650-741 |
DRI_Background |
denotes |
The CD44+/CD24-/ALDH+ cell population was increased in DCIS.com cells that expressed SOX11. |
| T8 |
742-754 |
REPLACED |
denotes |
Upregulating |
| T9 |
755-760 |
Token_Label.OUTSIDE |
denotes |
SOX11 |
| T10 |
761-937 |
DRI_Outcome |
denotes |
expression in DCIS.com cells led to increased invasive growth both in vitro and when they were injected intraductally in a mouse model of DCIS that recapitulates human disease. |
| T11 |
938-1097 |
DRI_Background |
denotes |
Invasive lesions formed sooner and tumour growth was augmented in vivo, suggesting that SOX11 contributes to the progression of DCIS to invasive breast cancer. |
| T12 |
1098-1330 |
DRI_Outcome |
denotes |
We identified potential downstream effectors of SOX11 during both microinvasive and invasive tumour growth stages, including several with established links to regulation of progenitor cell function and prenatal developmental growth. |
| T13 |
1331-1516 |
DRI_Outcome |
denotes |
Our findings suggest that SOX11 is a potential biomarker for DCIS lesions containing cells harbouring distinct biological features that are likely to progress to invasive breast cancer. |
| T14 |
1517-1536 |
DRI_Unspecified |
denotes |
© 2017 The Authors. |
| T15 |
1537-1660 |
DRI_Background |
denotes |
The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland. |